Key Highlights

  • Foundry losses: Intel Foundry reported a loss of around $2.1 billion in Q2 2026, though management framed the narrowing as progress.
  • Manufacturing progress: Intel has reported improving yields on its advanced 18A process, with the future 14A node also in development.
  • Strategic significance: Intel's push to build a domestic foundry carries geopolitical weight given the concentration of chip Manufacturing in Asia.
  • Execution risk: Winning outside customers who have manufacturing alternatives, and doing so profitably, remains the central unresolved question.

Intel (NASDAQ:INTC) is attempting one of the most difficult transformations in corporate technology: turning itself into a contract chip manufacturer that builds processors for other companies, not just its own. For Nasdaq 100 investors, the stakes are high and the Margin for error is thin, because the plan depends almost entirely on flawless execution of unproven manufacturing technology.

What Intel Does

Intel designs and manufactures processors, the chips at the heart of most personal computers and many servers. It sits in the technology sector. For decades it both designed and built its own chips, a model that once made it the most valuable semiconductor company in the world. After falling behind rivals in manufacturing, it is now trying to rebuild its lead while also opening its factories to outside customers through a Business it calls Intel Foundry.

A Costly Turnaround

The turnaround is expensive and slow. In the second quarter of 2026 Intel Foundry reported a loss of around 2.1 billion US dollars, though the company framed the narrowing of losses as progress. Much rides on its advanced manufacturing processes, known as 18A and the future 14A, where Intel has reported improving yields, the proportion of chips that come out working. Better yields are the difference between a factory that loses money and one that earns it, which is why every incremental improvement is watched so intently.

Why it Matters for the Nasdaq 100

Intel is a long-standing member of the index and a symbol of American semiconductor manufacturing. Its attempt to build a domestic foundry has strategic significance well beyond its share price, given the geopolitical importance of chip production. For investors, Intel offers a different kind of bet from the AI winners: a recovery story whose success is far from guaranteed. If the foundry succeeds, the reward could be substantial; if it falters, the losses could persist, making Intel one of the more uncertain names in the benchmark.

The Risks to Weigh

The risks are considerable. Advanced manufacturing is extraordinarily difficult, and delays or disappointing yields would undermine the entire plan. Intel must also win outside customers who have alternatives, and persuading them to trust a newcomer takes time. The Capital required is enormous, pressuring cash flow, and competition in its core processor markets remains fierce, including from companies designing their own chips. There is execution risk at almost every turn, and patience among investors is not unlimited.

Why the Stakes Reach Beyond Intel

It is worth appreciating why so many observers, including governments, are willing Intel to succeed. Advanced chip manufacturing is concentrated in a handful of places, most of them in Asia, and that concentration has come to be seen as a strategic vulnerability. A revived Intel foundry would offer the West a leading-edge alternative, which is why the effort has attracted political support and subsidies. For investors, that backing can cushion some of the risk, but it does not remove it: subsidies help fund factories, yet they cannot conjure the customers or the manufacturing yields that ultimately determine whether the business earns its keep.

What to Watch Next

Readers should follow the losses at Intel Foundry and whether they continue to narrow, since a path to break-even is the central question. Announcements of external customers committing to Intel's manufacturing would be powerful evidence that the strategy is working. Progress on 18A and 14A yields is the technical heart of the story, so any concrete detail matters. Capital-spending plans reveal how much cash the effort is consuming. Finally, watch the health of Intel's traditional processor business, because steady Revenue there provides the funding and the time the company needs to prove that its ambitious and costly foundry gamble can eventually pay off for the patient shareholders who have already waited a long while indeed.

A Costly Bet With National Stakes

Intel's foundry ambition is as much a national project as a corporate one, which cuts both ways for investors. Government support can cushion the cost of an extraordinarily difficult manufacturing turnaround, but it cannot manufacture the yields or the customers that will ultimately decide whether the bet pays off. Patience remains the price of admission for anyone backing this recovery.